Bezafibrate in severe liver toxicity due to ibrutinib

Authors

  • Roni Nasser Liver Unit, Rambam Health Care Campus, Haifa; Department of Gastroenterology, Rambam Health Care Campus, Haifa; Internal Medicine B, Rambam Health Care Campus
  • Nemer Sayed Ahmad Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel
  • Ella Veitsman Liver Unit, Rambam Health Care Campus, Haifa; Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel
  • Tarek Saadi Liver Unit, Rambam Health Care Campus, Haifa; Department of Gastroenterology, Rambam Health Care Campus, Haifa; Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel

DOI:

https://doi.org/10.15403/jgld-4717

Keywords:

ibrutinib, hepatotoxicity

Downloads

Published

2023-04-01

How to Cite

1.
Nasser R, Sayed Ahmad N, Veitsman E, Saadi T. Bezafibrate in severe liver toxicity due to ibrutinib. JGLD [Internet]. 2023 Apr. 1 [cited 2026 Jul. 15];32(1):119-20. Available from: https://www.jgld.ro/jgld/index.php/jgld/article/view/4717

Issue

Vol. 32 No. 1: March 2023

Section

Letters